drugset / Trial / NCT02438397

the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix Insulin

NCT02438397

Phase 4 Unknown 80 enrolled Shanghai 6th People's Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

the study objective: to explore the efficacy of acarbose and metformin on glucose fluctuations as add on therapy in type 2 diabetes patients inadequately controlled with premix insulin.

Timeline

Start
2014-12
Primary completion
2016-10
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Acarbose Unknown 100 mg
Comparator Metformin Small molecule 500 mg
Background premix insulin Unknown